Quick Answer
ASCENTAGE PHARMA GROUP INTERNATIONAL reported Gross Profit of $951.57 million for the year ending 2024.
- ASCENTAGE PHARMA GROUP INTERNATIONAL showed an increase of +397.1% in Gross Profit from 2023 to 2024.
- This data is from ASCENTAGE PHARMA GROUP INTERNATIONAL's annual report (Form 10-K), filed with the SEC on April 16, 2025.
- XBRL data for this metric is available from 2022 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2022 to 2024), ASCENTAGE PHARMA GROUP INTERNATIONAL's Gross Profit has grown by 406.9%.
- Historical annual values: Fiscal year 2024: $951.57 million | Fiscal year 2023: $191.44 million | Fiscal year 2022: $187.71 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: